Parvovirus B-19 infection during pregnancy

Infectious Disease in Obstetrics and Gynecology

Volumn 11, Issue 3, 2003, Pages 175-179

  Al Khan, Anthony ^a   Caligiuri, Andrew ^a   Apuzzio, Joseph ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Perinatal Infection; Pregnancy; Virus

Indexed keywords

VIRUS VECTOR;

ACUTE DISEASE; ADULT; ANEMIA; CLINICAL OBSERVATION; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EARLY DIAGNOSIS; FATALITY; FEMALE; FETUS; FETUS HYDROPS; FETUS WASTAGE; HUMAN; INFECTION PREVENTION; INTRAUTERINE BLOOD TRANSFUSION; PARVOVIRUS; PERINATAL MORTALITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; SERODIAGNOSIS; VIRUS INFECTION; VIRUS INFECTIVITY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL CARE; PROGNOSIS; RISK ASSESSMENT;

EID: 0347354765     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440300025518     Document Type: Review

References (38)

1. Shapiro L. The numbered diseases: first through sixth. J Am Med Assoc 1965;194:210
2. Cossart YE, Field AM, Cant B, et al. Parvovirus-like particles in human sera. Lancet 1975;1:72-3
3. Anderson MJ, Jones SE, Fisher-Jock SP, et al. Human parvovirus, the cause of erythema infectiosum (Fifth disease)? Lancet 1983;1:1378
4. Mandell GL, Bennett JE, Dolin R. Mandell: Principles and Practice of Infectious Diseases, 5th edn. New York: Churchill Livingstone, 2000:1685-7
5. Meyers C, Mane M, Kokorina N, et al. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology 2000;272:338-46
6. Weigel-Kelley KA. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 2001;75:4110-16
7. Young N, Harrison M, Moore J, et al. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest 1989;84:1114-23
8. Agar EA, Chin TDY, Poland JD. Epidemic erythema infectiosum. N Engl J Med 1966;275:1326-31
9. Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149:1153-6
10. Joseph PR. Fifth disease: the frequency of joint involvement in adults. NY State J Med 1986;86:560-3
11. Klouda PT, Corbin SA, Bradley BA, et al. HLA and acute arthritis following human parvovirus infection. Tissue Antigens 1986;28:318-19
12. OBGYN.net. New Process Screens Plasma for Human Parvovirus B19, 2000: http://www.obgyn.net/ newsrx/womens_health-blood_safety-20001225-1 .asp
13. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus B19 infection in pregnancy. Br Med J 1990;30:1166-70
14. Van Elsacker-Niele AM, Salimans MM, Weiand HT, et al. Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol 1989;96:768-75
15. Rodis JF, Quinn DL, Gary GW Jr, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990;163:1168-71
16. Markenson GR, Yancey ML. Parvovirus B19 infections in pregnancy. Semin Perinatol 1998;22:309
17. Brown KE, Green S, Antunez-de-Mayolo J. Congenital anemia following transplacental B19 parvovirus infection. Lancet 1994;343:895
18. Brown T, Anand A, Ritchie LD, et al. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984;2:1033-4
19. Fairley C, Smoliniec J, Caul O, et al. Observational study of the effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995:346:1335
20. Young NS, Mortimer PP, Moore JG, et al. Characterization of a virus that causes transient aplastic crisis. J Clin Invest 1984;73:224-30
21. Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:8227-32
22. Karetnyi YV, Beck PR, Markin RS, et al. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 1999;144:1713-24
23. Saal JG, Stendle M, Einsele H, et al. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatology 1992;12:147-51
24. Schwarz TF, Jager G, Gilch S. Comparison of seven commercial tests for the detection of parvovirus B19-specific IgM. Zentralbl Bakteriol 1997;285:525
25. Torok T. Human parvovirus B19. In Remington J, Klein J, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, PA: Saunders, 1995:668-73
26. Sloots T. Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19. Eur J Clin Microbiol Infect Dis 1996;15:758-61
27. Yamakawa Y, Oka H, Hori S, et al. Detection of human parvovirus bv nested polymerase chain reaction. Obstet Gynecol 1995;86:126-9
28. Miller E, Jairley CK, Cohen BJ, et al. Immediate and long-term outcome of human parvovirus B19 in pregnancy. Br J Obstet Gynaecol 1998;105:174-8
29. Bahado-Singh RO. Middle cerebral artery Doppler velocimetric deceleration angle as a predictor of fetal anemia in Rh-allo immunized fetuses without hydrops. Am J Obstet Gynecol 2000;183:746-51
30. Sheikh AU, Ernest JM, O'Shea M. Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 1992;167:461-6
31. Cosmi E, Mari G, Delle Chiaie L, et al. Non-invasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002;187:1290-3
32. Humphrey W, Magoon M, O'Shaughnessy T. Severe non-immune hydrops secondary to parvovirus B19 infection: spontaneous reversal in-utero and survival of a term infant. Obstet Gynecol 1991;78:900-2
33. Pryde PG, Nugent CE, Pridjian G, et al. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet Gynecol 1992;79:859
34. Adler SP. Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 1993;168:361-8
35. Rotbart HA. Human parvovirus infections. Annu Rev Med 1990;41:25-34
36. Eis-Hübinger AM, Dieck D, Schild R, et al. Parvovirus B19 infection in pregnancy. Intervirology 1998;41:178-84
37. Torok TS, Wang QY, Gary GW, et al. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992;14:149-55
38. Clewley JP. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 1989;27:2647-51